Latest On Moleculin Biotech, Inc (MBRX):
About Moleculin Biotech, Inc (MBRX):
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors, as well as to treat pancreatic cancer, AML, and glioblastoma. It also develops WP1220, an analog of WP1066, which has completed Phase 1 clinical trial for the topical treatment of cutaneous T-cell lymphoma in Poland; WP1234 for the treatment of pancreatic cancer; and WP1732, an analog of WP1066 for the treatment of AML, pancreatic, and other cancers. The company's lead metabolism/glycosylation inhibitor compound is WP1122 to treat cancers and viruses. In addition, it engages in the preclinical development of other drug candidates, including other immune/transcription modulators and metabolism/glycosylation inhibitors. The company has partnerships and collaboration agreement with The University of Texas MD Anderson Cancer Center, Emory University, Mayo Clinic Research Endeavor, The University of Iowa, Medical University of Gdansk, University of Bergen, DERMIN Sp. z o. o., and WPD Pharmaceuticals Sp z.o.o for the development of various drug candidates. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas.
General
- Name Moleculin Biotech, Inc
- Symbol MBRX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 11
- Last Split Factor1:6
- Last Split Date2021-02-01
- Fiscal Year EndDecember
- IPO Date2016-06-02
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.moleculin.com
Valuation
- Price/Book (Most Recent Quarter) 8.31
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.10
- Return on Assets -46%
- Return on Equity -111%
- Earnings Per Share -$0.32
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 122.21 million
- EBITDA -14983000
- Analyst Target Price $19.67
- Book Value Per Share $1.41
Share Statistics
- Shares Outstanding 28.42 million
- Shares Float 9.99 million
- % Held by Insiders 1116%
- % Held by Institutions 22.85%
- Shares Short 602462
- Shares Short Prior Month 416454
- Short Ratio 0.11
- Short % of Float 2%
- Short % of Shares Outstanding 2%
Technicals
- Beta 2.08
- 52 Week High $9.3
- 52 Week Low $3.16
- 50 Day Moving Average 4.7
- 200 Day Moving Average 4.87
Dividends
- Dividend Date 2021-02-01
- ExDividend Date N/A
- Dividend Yield 0%
Moleculin Biotech, Inc (MBRX) Dividend Calendar:
MBRX's last dividend payment was made to shareholders on February 1, 2021.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Moleculin Biotech, Inc (MBRX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-12 | $N/A | -$0.60 | -$0.56 | -6.98% |
2020-06-30 | 2020-08-12 | $N/A | -$0.51 | -$0.54 | 6.35% |
2020-03-31 | 2020-05-11 | $N/A | -$0.61 | -$0.60 | -1.2% |
2019-12-31 | 2020-03-19 | $N/A | -$0.67 | -$0.60 | -10.9% |
2019-09-30 | 2019-11-12 | $N/A | -$0.56 | -$0.52 | -8.23% |
2019-06-30 | 2019-08-16 | $N/A | -$0.51 | -$0.72 | 28.67% |
2019-03-31 | 2019-05-13 | $N/A | -$0.84 | -$0.54 | -55.56% |
2018-12-31 | 2019-02-21 | $N/A | -$0.60 | -$0.60 | 0% |
2018-09-30 | 2018-11-13 | $N/A | -$0.48 | -$0.78 | 38.46% |
2018-06-30 | 2018-08-10 | $N/A | -$1.20 | -$0.84 | -42.86% |
2018-03-31 | 2018-05-14 | $N/A | -$0.68 | -$0.84 | 19.29% |
2017-12-31 | 2018-03-28 | $N/A | -$1.01 | -$0.72 | -40.32% |
2017-09-30 | 2017-11-13 | $N/A | -$0.84 | ||
2017-06-30 | 2017-08-14 | $N/A | -$0.19 | ||
2017-03-31 | 2017-04-03 | $N/A | -$0.12 | -$0.11 | -9.09% |
2016-09-30 | 2016-11-21 | $N/A | -$0.12 | -$0.11 | -12.45% |
2016-06-30 | 2016-08-15 | $N/A | -$0.08 |
Moleculin Biotech, Inc (MBRX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Moleculin Biotech, Inc (MBRX) Chart:
Moleculin Biotech, Inc (MBRX) News:
Below you will find a list of latest news for Moleculin Biotech, Inc (MBRX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Moleculin Biotech, Inc (MBRX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest MBRX Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 2:42 PM EST | 300 | $1.39 |
Moleculin Biotech, Inc (MBRX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000165/0001659617-20-000165-index.htm |
2018-07-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1659617/000000000018022235/0000000000-18-022235-index.htm |
2018-10-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1659617/000000000018033221/0000000000-18-033221-index.htm |
2020-01-06 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1659617/000000000020000106/0000000000-20-000106-index.htm |
2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000090266420000870/0000902664-20-000870-index.htm |
2019-04-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000091957419002792/0000919574-19-002792-index.htm |
2019-05-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000110465919026299/0001104659-19-026299-index.htm |
2020-02-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000110465920011647/0001104659-20-011647-index.htm |
2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000110465920011650/0001104659-20-011650-index.htm |
2020-02-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000110465920012016/0001104659-20-012016-index.htm |
2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000110465920013411/0001104659-20-013411-index.htm |
2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000110465920016402/0001104659-20-016402-index.htm |
2020-07-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000110465920084557/0001104659-20-084557-index.htm |
2020-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000110465920084563/0001104659-20-084563-index.htm |
2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000114420418033608/0001144204-18-033608-index.htm |
2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000114420418033609/0001144204-18-033609-index.htm |
2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000114420418033610/0001144204-18-033610-index.htm |
2018-06-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000114420418035170/0001144204-18-035170-index.htm |
2018-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420418035173/0001144204-18-035173-index.htm |
2018-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420418052779/0001144204-18-052779-index.htm |
2018-10-15 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1659617/000114420418053847/0001144204-18-053847-index.htm |
2018-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420418053855/0001144204-18-053855-index.htm |
2018-10-25 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1659617/000114420418055201/0001144204-18-055201-index.htm |
2018-10-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1659617/000114420418055202/0001144204-18-055202-index.htm |
2018-10-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1659617/000114420418055246/0001144204-18-055246-index.htm |
2018-10-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1659617/000114420418055247/0001144204-18-055247-index.htm |
2018-10-29 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1659617/000114420418055878/0001144204-18-055878-index.htm |
2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420419000916/0001144204-19-000916-index.htm |
2019-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420419001760/0001144204-19-001760-index.htm |
2019-03-26 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000114420419016030/0001144204-19-016030-index.htm |
2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420419016392/0001144204-19-016392-index.htm |
2019-03-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000114420419016728/0001144204-19-016728-index.htm |
2019-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420419020801/0001144204-19-020801-index.htm |
2019-04-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000114420419020802/0001144204-19-020802-index.htm |
2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000114420419028195/0001144204-19-028195-index.htm |
2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000114420419028196/0001144204-19-028196-index.htm |
2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000114420419028197/0001144204-19-028197-index.htm |
2019-07-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1659617/000114420419035669/0001144204-19-035669-index.htm |
2019-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000114420419035673/0001144204-19-035673-index.htm |
2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920019124/0001437749-20-019124-index.htm |
2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920019447/0001437749-20-019447-index.htm |
2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920019673/0001437749-20-019673-index.htm |
2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920019676/0001437749-20-019676-index.htm |
2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920020383/0001437749-20-020383-index.htm |
2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920020551/0001437749-20-020551-index.htm |
2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920020687/0001437749-20-020687-index.htm |
2020-10-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000143774920020741/0001437749-20-020741-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000143774920020742/0001437749-20-020742-index.htm |
2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920020761/0001437749-20-020761-index.htm |
2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920020853/0001437749-20-020853-index.htm |
2020-10-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920021042/0001437749-20-021042-index.htm |
2020-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920021357/0001437749-20-021357-index.htm |
2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000143774920021911/0001437749-20-021911-index.htm |
2019-01-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000153561019000016/0001535610-19-000016-index.htm |
2019-04-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000153561019000082/0001535610-19-000082-index.htm |
2020-01-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000153561020000019/0001535610-20-000019-index.htm |
2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1659617/000153561020000066/0001535610-20-000066-index.htm |
2018-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000071/0001659617-18-000071-index.htm |
2018-06-25 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000074/0001659617-18-000074-index.htm |
2018-06-27 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000077/0001659617-18-000077-index.htm |
2018-07-12 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000084/0001659617-18-000084-index.htm |
2018-07-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000086/0001659617-18-000086-index.htm |
2018-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000093/0001659617-18-000093-index.htm |
2018-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000096/0001659617-18-000096-index.htm |
2018-09-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000103/0001659617-18-000103-index.htm |
2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000109/0001659617-18-000109-index.htm |
2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000110/0001659617-18-000110-index.htm |
2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961718000112/0001659617-18-000112-index.htm |
2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000003/0001659617-19-000003-index.htm |
2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000005/0001659617-19-000005-index.htm |
2019-02-21 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000018/0001659617-19-000018-index.htm |
2019-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000019/0001659617-19-000019-index.htm |
2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000022/0001659617-19-000022-index.htm |
2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000025/0001659617-19-000025-index.htm |
2019-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000030/0001659617-19-000030-index.htm |
2019-04-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000033/0001659617-19-000033-index.htm |
2019-04-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000037/0001659617-19-000037-index.htm |
2019-04-12 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000042/0001659617-19-000042-index.htm |
2019-04-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000047/0001659617-19-000047-index.htm |
2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000057/0001659617-19-000057-index.htm |
2019-05-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000059/0001659617-19-000059-index.htm |
2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000062/0001659617-19-000062-index.htm |
2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000069/0001659617-19-000069-index.htm |
2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000072/0001659617-19-000072-index.htm |
2019-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000077/0001659617-19-000077-index.htm |
2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000080/0001659617-19-000080-index.htm |
2019-07-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000084/0001659617-19-000084-index.htm |
2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000101/0001659617-19-000101-index.htm |
2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000102/0001659617-19-000102-index.htm |
2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000103/0001659617-19-000103-index.htm |
2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000104/0001659617-19-000104-index.htm |
2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000105/0001659617-19-000105-index.htm |
2019-07-15 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000106/0001659617-19-000106-index.htm |
2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000107/0001659617-19-000107-index.htm |
2019-07-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000114/0001659617-19-000114-index.htm |
2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000118/0001659617-19-000118-index.htm |
2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000125/0001659617-19-000125-index.htm |
2019-08-14 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000137/0001659617-19-000137-index.htm |
2019-08-16 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000144/0001659617-19-000144-index.htm |
2019-08-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000145/0001659617-19-000145-index.htm |
2019-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000152/0001659617-19-000152-index.htm |
2019-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000159/0001659617-19-000159-index.htm |
2019-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000161/0001659617-19-000161-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000169/0001659617-19-000169-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000170/0001659617-19-000170-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000173/0001659617-19-000173-index.htm |
2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000177/0001659617-19-000177-index.htm |
2019-12-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000186/0001659617-19-000186-index.htm |
2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000193/0001659617-19-000193-index.htm |
2019-12-23 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1659617/000165961719000202/0001659617-19-000202-index.htm |
2020-01-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000003/0001659617-20-000003-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000006/0001659617-20-000006-index.htm |
2020-01-17 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000011/0001659617-20-000011-index.htm |
2020-01-17 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000014/0001659617-20-000014-index.htm |
2020-01-21 | RW | Registration Withdrawal Request | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000016/0001659617-20-000016-index.htm |
2020-02-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000023/0001659617-20-000023-index.htm |
2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000026/0001659617-20-000026-index.htm |
2020-02-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000034/0001659617-20-000034-index.htm |
2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000038/0001659617-20-000038-index.htm |
2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000043/0001659617-20-000043-index.htm |
2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000047/0001659617-20-000047-index.htm |
2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000050/0001659617-20-000050-index.htm |
2020-03-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000055/0001659617-20-000055-index.htm |
2020-03-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000066/0001659617-20-000066-index.htm |
2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000068/0001659617-20-000068-index.htm |
2020-03-23 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000076/0001659617-20-000076-index.htm |
2020-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000079/0001659617-20-000079-index.htm |
2020-03-27 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000083/0001659617-20-000083-index.htm |
2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000087/0001659617-20-000087-index.htm |
2020-04-07 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000090/0001659617-20-000090-index.htm |
2020-04-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000092/0001659617-20-000092-index.htm |
2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000094/0001659617-20-000094-index.htm |
2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000097/0001659617-20-000097-index.htm |
2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000102/0001659617-20-000102-index.htm |
2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000106/0001659617-20-000106-index.htm |
2020-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000110/0001659617-20-000110-index.htm |
2020-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000113/0001659617-20-000113-index.htm |
2020-05-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000122/0001659617-20-000122-index.htm |
2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000124/0001659617-20-000124-index.htm |
2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000128/0001659617-20-000128-index.htm |
2020-05-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000132/0001659617-20-000132-index.htm |
2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000134/0001659617-20-000134-index.htm |
2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000138/0001659617-20-000138-index.htm |
2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000140/0001659617-20-000140-index.htm |
2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000144/0001659617-20-000144-index.htm |
2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000147/0001659617-20-000147-index.htm |
2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000151/0001659617-20-000151-index.htm |
2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000152/0001659617-20-000152-index.htm |
2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000153/0001659617-20-000153-index.htm |
2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000158/0001659617-20-000158-index.htm |
2020-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000161/0001659617-20-000161-index.htm |
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000165/0001659617-20-000165-index.htm |
2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000171/0001659617-20-000171-index.htm |
2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000172/0001659617-20-000172-index.htm |
2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000173/0001659617-20-000173-index.htm |
2020-07-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000178/0001659617-20-000178-index.htm |
2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000181/0001659617-20-000181-index.htm |
2020-07-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000183/0001659617-20-000183-index.htm |
2020-08-04 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000189/0001659617-20-000189-index.htm |
2020-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000196/0001659617-20-000196-index.htm |
2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000197/0001659617-20-000197-index.htm |
2020-08-21 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000204/0001659617-20-000204-index.htm |
2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000206/0001659617-20-000206-index.htm |
2020-08-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000211/0001659617-20-000211-index.htm |
2018-07-23 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1659617/999999999518001857/9999999995-18-001857-index.htm |
2018-10-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1659617/999999999518002729/9999999995-18-002729-index.htm |
2020-04-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1659617/999999999520000717/9999999995-20-000717-index.htm |
2018-07-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1659617/999999999718006898/9999999997-18-006898-index.htm |
Moleculin Biotech, Inc (MBRX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Moleculin Biotech, Inc (MBRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1116%Institutional Ownership: 2285%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-07-13 | WALTER V KLEMP | CEO and President | Buy | 79,227.00 | 1,046,951.00 | https://www.sec.gov/Archives/edgar/data/1659617/000165961720000178/0001659617-20-000178-index.htm |